First Sale of FelixTM in Research Application
Filed with ASX · · 2 pages · English
• Maiden sale of Felix device to Diagens Biotechnology Company Ltd, a Chinese manufacturer and distributor of proprietary and third-party human reproduction products to its extensive network ofassisted reproduction centers and prenatal diagnosis centers throughout China • Sale valued at $11,000 for a console and starter pack of cartridges for research applications represents a “pathfinder” sale in
Earlier from Memphasys
- Verification and Validation Assessments Complete
- MEM: Reaches settlement agreement with Hydrix
- Memphasys completes $3m capital raise
- Quarterly Cashflow Report
- Quarterly Activities Report
Later from Memphasys
- First Felix System commercial sale for clinical IVF use
- Appendix 4D and Half Year Report and Accounts
- MEM Achieves ISO 13485 Compliance
- Follow up sales of FelixTM System
- Felix System commercialisation update
Follow Memphasys into a list and get an email when it puts out news.
Follow Memphasys